Product Code: ETC4746652 | Publication Date: Nov 2023 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
The Canada Influenza Vaccine Market is poised for steady growth rate improvements from 2025 to 2029. Commencing at 6.28% in 2025, growth builds up to 6.76% by 2029.
The influenza vaccine market in Canada is a critical component of public health efforts to prevent seasonal flu outbreaks. The market is driven by the annual need for updated vaccines to match circulating influenza strains, government vaccination programs, and public health initiatives. Advances in vaccine technology, such as the development of new vaccine formulations and delivery methods, are influencing the market dynamics. The emphasis on increasing vaccination coverage and improving vaccine efficacy contributes to the growth of the influenza vaccine market in Canada.
The influenza vaccine market in Canada is driven by increasing awareness of flu prevention and government initiatives aimed at immunization. The need for effective and affordable vaccines, particularly among vulnerable populations such as the elderly and children, is further boosting the market.
The Canada Influenza Vaccine Market is confronted with challenges related to vaccine production and distribution, including managing supply chain complexities and ensuring timely availability. There are also issues with public vaccination uptake and vaccine hesitancy, which can impact overall market performance.
Canadian policies regarding the influenza vaccine market emphasize public health and safety. The government supports vaccination programs through funding and public health campaigns aimed at increasing vaccine uptake. Regulations ensure that influenza vaccines meet high standards for safety and efficacy. The Canadian government also provides incentives for research and development of new vaccine technologies and improved formulations.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Canada Influenza Vaccine Market Overview |
3.1 Canada Country Macro Economic Indicators |
3.2 Canada Influenza Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Canada Influenza Vaccine Market - Industry Life Cycle |
3.4 Canada Influenza Vaccine Market - Porter's Five Forces |
3.5 Canada Influenza Vaccine Market Revenues & Volume Share, By Vaccine type, 2021 & 2031F |
3.6 Canada Influenza Vaccine Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Canada Influenza Vaccine Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.8 Canada Influenza Vaccine Market Revenues & Volume Share, By Age Group, 2021 & 2031F |
3.9 Canada Influenza Vaccine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
4 Canada Influenza Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of influenza vaccination |
4.2.2 Government initiatives promoting influenza vaccination programs |
4.2.3 Growing elderly population in Canada |
4.2.4 Technological advancements in vaccine production |
4.2.5 Rising prevalence of influenza outbreaks |
4.3 Market Restraints |
4.3.1 Limited access to healthcare services in remote areas |
4.3.2 Vaccine supply chain challenges |
4.3.3 Vaccine hesitancy among certain population groups |
4.3.4 High cost of vaccine development and distribution |
4.3.5 Competition from alternative preventive measures |
5 Canada Influenza Vaccine Market Trends |
6 Canada Influenza Vaccine Market Segmentations |
6.1 Canada Influenza Vaccine Market, By Vaccine type |
6.1.1 Overview and Analysis |
6.1.2 Canada Influenza Vaccine Market Revenues & Volume, By Quadrivalent, 2021-2031F |
6.1.3 Canada Influenza Vaccine Market Revenues & Volume, By Trivalent, 2021-2031F |
6.2 Canada Influenza Vaccine Market, By Type |
6.2.1 Overview and Analysis |
6.2.2 Canada Influenza Vaccine Market Revenues & Volume, By Seasonal, 2021-2031F |
6.2.3 Canada Influenza Vaccine Market Revenues & Volume, By Pandemic, 2021-2031F |
6.3 Canada Influenza Vaccine Market, By Technology |
6.3.1 Overview and Analysis |
6.3.2 Canada Influenza Vaccine Market Revenues & Volume, By Egg-based, 2021-2031F |
6.3.3 Canada Influenza Vaccine Market Revenues & Volume, By Cell-based, 2021-2031F |
6.4 Canada Influenza Vaccine Market, By Age Group |
6.4.1 Overview and Analysis |
6.4.2 Canada Influenza Vaccine Market Revenues & Volume, By Pediatric, 2021-2031F |
6.4.3 Canada Influenza Vaccine Market Revenues & Volume, By Adult, 2021-2031F |
6.5 Canada Influenza Vaccine Market, By Route of Administration |
6.5.1 Overview and Analysis |
6.5.2 Canada Influenza Vaccine Market Revenues & Volume, By Injection, 2021-2031F |
6.5.3 Canada Influenza Vaccine Market Revenues & Volume, By Nasal Spray, 2021-2031F |
7 Canada Influenza Vaccine Market Import-Export Trade Statistics |
7.1 Canada Influenza Vaccine Market Export to Major Countries |
7.2 Canada Influenza Vaccine Market Imports from Major Countries |
8 Canada Influenza Vaccine Market Key Performance Indicators |
8.1 Percentage increase in influenza vaccination coverage rates |
8.2 Number of government-funded influenza vaccination campaigns |
8.3 Research and development investment in new vaccine technologies |
8.4 Number of reported influenza cases in Canada |
8.5 Rate of vaccine uptake among high-risk populations |
9 Canada Influenza Vaccine Market - Opportunity Assessment |
9.1 Canada Influenza Vaccine Market Opportunity Assessment, By Vaccine type, 2021 & 2031F |
9.2 Canada Influenza Vaccine Market Opportunity Assessment, By Type, 2021 & 2031F |
9.3 Canada Influenza Vaccine Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.4 Canada Influenza Vaccine Market Opportunity Assessment, By Age Group, 2021 & 2031F |
9.5 Canada Influenza Vaccine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
10 Canada Influenza Vaccine Market - Competitive Landscape |
10.1 Canada Influenza Vaccine Market Revenue Share, By Companies, 2024 |
10.2 Canada Influenza Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |